Yseop
AI software company that turns data into written insight in real time.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Late VC | |
| Total Funding | 000k | ||
| EUR | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | 49 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | 16 % |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | (24 %) | (21 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Yseop is an enterprise software company that specializes in artificial intelligence, with a focus on Natural Language Generation (NLG) for regulated industries. The company primarily serves the life sciences and pharmaceutical sectors.
Yseop provides a no-code, AI-powered platform designed to automate the creation of complex and regulated documentation. This platform functions as a "Copilot" for medical writers and other professionals, streamlining the process of generating reports for clinical trials and other regulatory submissions. The technology is built to ensure accuracy and compliance, significantly accelerating workflows from the initial draft to the final submission.
The business model is centered on providing its software platform to enterprises (B2B). By automating report generation, Yseop enables its clients to enhance productivity and reduce the time and resources spent on documentation. The company was founded in 2000 and has offices in Europe and the Americas, including Paris, New York, Lyon, and Bogota.
Keywords: NLG, Generative AI, Report Automation, Life Sciences, Pharmaceutical, Regulatory Compliance, Medical Writing, No-Code Platform, Clinical Trials, Data Analysis